biotechnology company
FyMed Expands Its Discovery and Drug Development Plans Through Innovative Strategies in Precision Medicine
20/09/15 02:21
FyMed, Inc. today announced strategic and operational expansion plans following the successful completion of major preclinical drug studies utilizing innovative companion diagnostic and prognostic technologies in precision medicine.
Read More...
Read More...
FyMed Reinforces Its Drug Development Pipeline With Novel Strategies in Precision Medicine
02/10/12 02:16
FyMed, Inc., a pharmaceutical company utilizing proprietary methodologies in evidence-based medicine for drug discoveries recently announced plans for the strategic and operational reinforcements of their drug development pipeline through innovative approaches in precision medicine. Read More...